Product Images Fulvestrant

Fulvestrant Injection is a medication available in the form of two single-dose prefilled syringes, each containing 250 mg/5 mL (50 mg/mL) and two SurGuard 3 Safety shielding intramuscular injection needles. The medication is used through intramuscular use only and needs to be discarded after use. Each syringe must be received to get the 500 mg dose. The GTIN number is 343808262021, and the NDC number is 43598-262-02. The medication needs to be refrigerated at 2° to 8°C (36° to 46°F) and stored in the original carton until the time of use to protect it from light. The text suggests that the medication is manufactured in India.*

The text format does not provide a clear understanding of its purpose or context. Therefore, a useful description cannot be generated.*

This is a graph showing survival probability over time for two groups of patients. The first group of 446 patients were treated with Fulvestrant plus Abemaciclib, while the second group of 223 patients received Fulvestrant plus Placebo. The X-axis represents time in months and the Y-axis represents survival probability. The number of patients at risk is also shown for each group at various time points.*

This is a clinical trial report showing the results of a study comparing the effectiveness of RUVETRAN bocic (1 484) versus RUVESTRAT Placebo (V = 242) in treating something related to a health condition. The study tracks the probability of an event occurring over a span of time, shown on a graph where the x-axis is in months. The numbers on the y-axis represent the number of participants in the study. The data shows that RUVETRAN bocic outperforms the placebo over time in reducing the probability of the event occurring.*

The text is not readable.*

This is a list of different types of activation methods including Finger Activation, Thumb Activation and Surface Activation. No further information is available.*